Guinea vs Philippines: HIV/AIDS deaths averted by antiretroviral therapy
Guinea
6,473 deaths
in 2024
Philippines
5,500 deaths
in 2024
Guinea rank
31st
Philippines rank
34th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Guinea
- Philippines
How they compare
Guinea currently reports 6,473 deaths against 5,500 deaths in Philippines, a difference of 973 deaths.
That makes Guinea's figure about 1.2 times Philippines's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Philippines ahead.
Guinea ranks 31st and Philippines ranks 34th of 157 countries.
Guinea has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Guinea | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 690.29 deaths | 23.06 deaths | 667.24 deaths | Guinea |
| 2010s | 3,770 deaths | 1,105 deaths | 2,665 deaths | Guinea |
| 2020s | 5,733 deaths | 4,288 deaths | 1,445 deaths | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Guinea or Philippines?
- Guinea, at 6,473 deaths against 5,500 deaths in Philippines as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Guinea and Philippines?
- 973 deaths, with Guinea ahead.
- How many years of comparable data are there for Guinea and Philippines?
- 35 years are reported by both, from 1990 to 2024.
- How do Guinea and Philippines rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Guinea ranks 31st and Philippines ranks 34th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.